Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065143
  • May 2021
  • Pharmaceuticals
  • 118 Pages
The global Influenza Vaccines market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Influenza Vaccines market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Influenza Vaccines market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Influenza Vaccines market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered F. Hoffmann-La Roche Ltd, Abbott, Seqirus, Sanofi, GlaxoSmithKline plc., Hualan Biological Engineering Inc, Mitsubishi Tanabe Pharma Corporation., Pfizer Inc., Merck & Co., Inc., AstraZeneca
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Influenza Vaccines market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Influenza Vaccines market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Influenza Vaccines market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Influenza Vaccines market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Influenza Vaccines Market:
The Influenza Vaccines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. F. Hoffmann-La Roche Ltd, Abbott, Seqirus, Sanofi, GlaxoSmithKline plc., Hualan Biological Engineering Inc, Mitsubishi Tanabe Pharma Corporation., Pfizer Inc., Merck & Co., Inc., AstraZeneca

Influenza Vaccines Market Segment Analysis:
by Vaccine Type
Quadrivalent Vaccines
Trivalent Vaccines
Virus Type
Influenza Virus Type A
Influenza Virus Type B
Age Group
Pediatrics
Adult

Geographic Coverage for Influenza Vaccines Market:
The market research report on global Influenza Vaccines market offers complete analysis across various regions across the world. The Influenza Vaccines market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Influenza Vaccines market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Influenza Vaccines Market Value and Forecast
  • US
  • Canada
Europe Influenza Vaccines Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Influenza Vaccines Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Influenza Vaccines Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Influenza Vaccines Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Influenza Vaccines market report:
  • The report provides key trends of the global Influenza Vaccines market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Influenza Vaccines industry
  • The report covers all the recent developments of the Influenza Vaccines market and helps to provide current industry updates
  • The report covers a detailed look over the global Influenza Vaccines Industry and provides with significant actionable insights
  • The Influenza Vaccines market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Influenza Vaccines market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Influenza Vaccines market
  • Comprehensive analysis of the Influenza Vaccines market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Influenza Vaccines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Influenza Vaccines market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Influenza Vaccines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Influenza Vaccines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Influenza Vaccines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Seqirus
  • Sanofi
  • GlaxoSmithKline plc.
  • Hualan Biological Engineering Inc
  • Mitsubishi Tanabe Pharma Corporation.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca
  • Quadrivalent Vaccines
  • Trivalent Vaccines
  • Pediatrics
  • Adult

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Influenza Vaccines Market Snapshot
          2.1.1. Global Influenza Vaccines Market By Vaccine Type,2019
               2.1.1.1.Quadrivalent Vaccines
               2.1.1.2.Trivalent Vaccines
          2.1.2. Global Influenza Vaccines Market By Age Group,2019
               2.1.2.1.Pediatrics
               2.1.2.2.Adult
          2.1.3. Global Influenza Vaccines Market By End-use,2019
          2.1.4. Global Influenza Vaccines Market By Geography,2019

3. Global Influenza Vaccines Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Vaccine Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Vaccine Type, 2020
     4.2. Global Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028

5. Global Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Age Group, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Age Group, 2020
     5.2. Global Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028

6. Global Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028

7. Global Influenza Vaccines Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Influenza Vaccines Market Analysis, 2018 – 2028 
          7.2.1. North America Influenza Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.2.3. North America Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028
          7.2.4. North America Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Influenza Vaccines Market Analysis, 2018 – 2028 
          7.3.1.  Europe Influenza Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.3.3. Europe Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028
          7.3.4. Europe Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Influenza Vaccines Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Influenza Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.4.3. Asia Pacific Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028
          7.4.4. Asia Pacific Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Influenza Vaccines Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Influenza Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.5.3. Latin America Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028
          7.5.4. Latin America Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Influenza Vaccines Market Analysis, 2018 – 2028 
          7.6.1.  MEA Influenza Vaccines Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Influenza Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.6.3. MEA Influenza Vaccines Market Size (US$), By Age Group, 2018 – 2028
          7.6.4. MEA Influenza Vaccines Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Influenza Vaccines Providers
        8.4.1 F. Hoffmann-La Roche Ltd
                8.4.1.1 Business Description
                8.4.1.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.1.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.1.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.1.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.2 Abbott
                8.4.2.1 Business Description
                8.4.2.2 Abbott Geographic Operations
                8.4.2.3 Abbott Financial Information
                8.4.2.4 Abbott Product Positions/Portfolio
                8.4.2.5 Abbott Key Developments
        8.4.3 Seqirus
                8.4.3.1 Business Description
                8.4.3.2 Seqirus Geographic Operations
                8.4.3.3 Seqirus Financial Information
                8.4.3.4 Seqirus Product Positions/Portfolio
                8.4.3.5 Seqirus Key Developments
        8.4.4 Sanofi
                8.4.4.1 Business Description
                8.4.4.2 Sanofi Geographic Operations
                8.4.4.3 Sanofi Financial Information
                8.4.4.4 Sanofi Product Positions/Portfolio
                8.4.4.5 Sanofi Key Developments
        8.4.5 GlaxoSmithKline plc.
                8.4.5.1 Business Description
                8.4.5.2 GlaxoSmithKline plc. Geographic Operations
                8.4.5.3 GlaxoSmithKline plc. Financial Information
                8.4.5.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.5.5 GlaxoSmithKline plc. Key Developments
        8.4.6 Hualan Biological Engineering Inc
                8.4.6.1 Business Description
                8.4.6.2 Hualan Biological Engineering Inc Geographic Operations
                8.4.6.3 Hualan Biological Engineering Inc Financial Information
                8.4.6.4 Hualan Biological Engineering Inc Product Positions/Portfolio
                8.4.6.5 Hualan Biological Engineering Inc Key Developments
        8.4.7 Mitsubishi Tanabe Pharma Corporation.
                8.4.7.1 Business Description
                8.4.7.2 Mitsubishi Tanabe Pharma Corporation. Geographic Operations
                8.4.7.3 Mitsubishi Tanabe Pharma Corporation. Financial Information
                8.4.7.4 Mitsubishi Tanabe Pharma Corporation. Product Positions/Portfolio
                8.4.7.5 Mitsubishi Tanabe Pharma Corporation. Key Developments
        8.4.8 Pfizer Inc.
                8.4.8.1 Business Description
                8.4.8.2 Pfizer Inc. Geographic Operations
                8.4.8.3 Pfizer Inc. Financial Information
                8.4.8.4 Pfizer Inc. Product Positions/Portfolio
                8.4.8.5 Pfizer Inc. Key Developments
        8.4.9 Merck & Co., Inc.
                8.4.9.1 Business Description
                8.4.9.2 Merck & Co., Inc. Geographic Operations
                8.4.9.3 Merck & Co., Inc. Financial Information
                8.4.9.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.9.5 Merck & Co., Inc. Key Developments
        8.4.10 AstraZeneca
                8.4.10.1 Business Description
                8.4.10.2 AstraZeneca Geographic Operations
                8.4.10.3 AstraZeneca Financial Information
                8.4.10.4 AstraZeneca Product Positions/Portfolio
                8.4.10.5 AstraZeneca Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Influenza Vaccines Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Influenza Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Influenza Vaccines Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Influenza Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Influenza Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Influenza Vaccines Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Influenza Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Influenza Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Influenza Vaccines Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Influenza Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Influenza Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Influenza Vaccines Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Influenza Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Influenza Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Influenza Vaccines Market Revenue, By Age Group, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Influenza Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Influenza Vaccines: Market Segmentation 
FIG. 2 Global Influenza Vaccines Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Influenza Vaccines Market, By Vaccine Type, 2019 (US$ Mn) 
FIG. 5 Global Influenza Vaccines Market, By Age Group, 2019 (US$ Mn) 
FIG. 6 Global Influenza Vaccines Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Influenza Vaccines Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Influenza Vaccines Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Influenza Vaccines Providers, 2019
FIG. 11 Global Influenza Vaccines Market Revenue Contribution, By Vaccine Type, 2019 & 2028 (Value %) 
FIG. 12 Global Influenza Vaccines Market Revenue Contribution, By Age Group, 2019 & 2028 (Value %) 
FIG. 13 Global Influenza Vaccines Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Influenza Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Influenza Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Influenza Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Influenza Vaccines Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Influenza Vaccines Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Influenza Vaccines market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Influenza Vaccines Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Influenza Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  North America Influenza Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  North America Influenza Vaccines Market Value, By Country, 2018 – 2028
TABLE  Europe Influenza Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Europe Influenza Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Europe Influenza Vaccines Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Influenza Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Influenza Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Influenza Vaccines Market Value, By Country, 2018 – 2028
TABLE  Latin America Influenza Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Influenza Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Influenza Vaccines Market Value, By Country, 2018 – 2028
TABLE  MEA Influenza Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  MEA Influenza Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  MEA Influenza Vaccines Market Value, By Country, 2018 – 2028
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Seqirus: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hualan Biological Engineering Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mitsubishi Tanabe Pharma Corporation.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Influenza Vaccines Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Influenza Vaccines Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Influenza Vaccines Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Influenza Vaccines Market, By Geography, 2019 (US$ Mn)
FIG.  Global Influenza Vaccines Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Influenza Vaccines Providers, 2016
FIG.  Global Influenza Vaccines Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Trivalent Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Influenza Vaccines Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Adult Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Influenza Vaccines Market Value, 2018 – 2028, (US$ Mn)